| |
|
|
|
Cancer Genetics Inc  
|
|
3.93 -0.02 (-0.01%) |
10-22 16:00 |
|
Open: |
3.96 |
Pre close: |
3.95 |
Target:
|
5.12
|
|
High: |
3.97 |
Low: |
3.87 |
Resistance:
|
4.38
4.90
|
|
Volume: |
9,193 |
Market Cap: |
10M |
Support:
|
3.55
2.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.02
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
4.11  |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
3.73 |
Stochastic Oscillator |
%K(14,3):
|
11.21 |
|
MA(250): |
3.92 |
%D(3): |
16.46 |
|
Average Volume(K) |
3-Month: |
198082
|
52-Week |
High:
|
10.39 |
|
10-Days: |
8465 |
Low: |
1.92 |
|
RSI |
RSI(14):
|
44.11 |
Change(%): |
3.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.568 |
Return on Equity (ttm) |
-152.3 |
Shares Out. (M) |
2.51 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-8.2 |
Shares Float (M) |
2.06 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.38 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-5.2 |
% Held by Institutions |
15.06 |
|
Forward EPS |
-0.750 |
Gross Profit (p.s.) |
1.434 |
Shares Short (K) |
46 |
|
Book Value (p.s.) |
2.260 |
EBITDA (p.s.) |
-1.016 |
P/E |
-6.92 |
|
Sales Per Share |
2.721 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.74 |
|
Profit Margin |
-17.53 |
Operating Cash Flow
(M) |
-5.70 |
P/S |
1.44 |
|
Operating Margin |
-46.98 |
Levered Free Cash Flow
(M) |
1.21 |
P/CF |
-1.73 |
|
|
|
|
|
|
